WallStreetZenWallStreetZen

NASDAQ: VNDA
Vanda Pharmaceuticals Inc Stock Ownership - Who owns Vanda Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Vanda Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Kevin Patrick MoranSVP CFO Treasurer2024-03-058,902$4.20
$37.41kSell
Gunther BirznieksSVP Business Development2024-03-058,684$4.13
$35.88kSell
Timothy WilliamsSVP General Counsel2024-03-058,941$4.18
$37.40kSell
Joakim WijkstromSVP Chief Marketing Officer2024-03-059,229$4.21
$38.83kSell
Mihael Hristos PolymeropoulosPresident and CEO2024-03-0524,288$4.13
$100.26kSell
Mihael Hristos PolymeropoulosPresident and CEO2024-03-0430,884$4.24
$131.07kSell
Kevin Patrick MoranSVP CFO Treasurer2024-03-045,798$4.48
$25.98kSell
Gunther BirznieksSVP Business Development2024-03-048,727$4.30
$37.49kSell
Joakim WijkstromSVP Chief Marketing Officer2024-03-047,498$4.41
$33.09kSell
Timothy WilliamsSVP General Counsel2024-03-048,147$4.41
$35.92kSell

1 of 2

VNDA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VNDA insiders and whales buy or sell their stock.

VNDA Shareholders

What type of owners hold Vanda Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
James E. Flynn15.07%8,669,076$39.53MInsider
Blackrock Inc14.51%8,346,367$38.06MInstitution
Renaissance Technologies LLC6.40%3,681,125$16.79MInstitution
Vanguard Group Inc6.01%3,456,087$15.76MInstitution
Kevin C. Tang4.72%2,715,852$12.38MInsider
Rho Ventures Iv LP4.38%2,518,177$11.48MInsider
Acadian Asset Management LLC3.93%2,263,132$10.32MInstitution
D E Shaw Co Inc3.67%2,112,125$9.63MInstitution
Morgan Stanley3.52%2,022,968$9.22MInstitution
Robert J. More3.47%1,995,976$9.10MInsider

1 of 3

VNDA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VNDA56.23%43.77%Net SellingNet Selling
CDXC8.22%91.78%Net Buying
ADAP7.28%92.72%Net Selling
MGX0.00%32.96%Net BuyingNet Buying
ENTA58.46%41.54%Net SellingNet Selling
View Top Biotech Stocks

Vanda Pharmaceuticals Stock Ownership FAQ

Who owns Vanda Pharmaceuticals?

Vanda Pharmaceuticals (NASDAQ: VNDA) is owned by 88.11% institutional shareholders, 68.59% Vanda Pharmaceuticals insiders, and 0.00% retail investors. James E. Flynn is the largest individual Vanda Pharmaceuticals shareholder, owning 8.67M shares representing 15.07% of the company. James E. Flynn's Vanda Pharmaceuticals shares are currently valued at $38.84M.

If you're new to stock investing, here's how to buy Vanda Pharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.